FIELD: medicine; pharmaceutics.
SUBSTANCE: present invention relates to sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine and pharmaceutically acceptable solvates thereof for use in treating and/or preventing motor neuron diseases and disorders of neuromuscular connections.
EFFECT: disclosed is use of sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1n-benzo[d]imidazol-2-amine and their solvates for treating motor neuron diseases and disorders of neuromuscular connections.
8 cl, 4 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SULPHATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOLE-2-AMINE, PREPARATION THEREOF AND USE OF SAME | 2013 |
|
RU2655454C2 |
| NEW COMBINATIONS OF NERAMEXANE FOR TREATING NEURODEGENERATIVE DISORDERS | 2008 |
|
RU2432161C1 |
| VACCINE AND METHOD FOR TREATING MOTOR NEURON DISEASES | 2002 |
|
RU2303996C2 |
| PHARMACEUTICAL COMPOSITION FOR INHIBITING AUTOPHAGY OF MOTOR NEURONS AND USE THEREOF | 2012 |
|
RU2585372C1 |
| TREATMENT OF NEUROLOGICAL DYSFUNCTION BY USING FRUCTOPYRANOSE AND ERYTHROPOIETIN SULFAMATES | 2002 |
|
RU2317086C2 |
| NEW OXIME CHOLEST-4-EN-3-ONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHOD FOR PREPARING | 2009 |
|
RU2496784C2 |
| MEDICAL COMPOSITION FOR TREATING MUSCULAR ATROPHY AND ASTHENIC BULBAR PARALYSIS AND METHOD FOR PREPARING THEREOF | 2006 |
|
RU2392955C2 |
| UROKINASE INHIBITORS ADMINISTRATION FOR TREATMENT AND/OR PREVENTION OF NEUROPATHOLOGICAL DISEASES | 2006 |
|
RU2410087C2 |
| TETRAHYDROISOQUINOLINE DERIVATIVES | 2017 |
|
RU2743424C2 |
| GENE THERAPY FOR NEURODEGENERATIVE DISORDERS | 2010 |
|
RU2603740C2 |
